| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGCGGAUAGAGGACACGACCAAGAUGGCGGCGGUGUCUGGCUUGGUGCG… | 1507 nt | 0.4433 | |
| AGCGGAUAGAGGACACGACCAAGAUGGCGGCGGUGUCUGGCUUGGUGCG… | 1453 nt | 0.4377 | |
| AGCGGAUAGAGGACACGACCAAGAUGGCGGCGGUGUCUGGCUUGGUGCG… | 1453 nt | 0.4336 |
The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and carbon dioxide, and provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle. The PDH complex is composed of multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3). The E1 enzyme is a heterotetramer of two alpha and two beta subunits. This gene encodes the E1 beta subunit. Mutations in this gene are associated with pyruvate dehydrogenase E1-beta deficiency. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2012]
A study in humans identified PDHB as one of six key differentially expressed cuproptosis-related genes (DECuGs) with diagnostic biomarker potential for sepsis, showing statistically significant dysregulation in validation cohorts [Wang et al. DOI:10.1016/j.heliyon.2024.e27379]. Single-cell RNA sequencing analysis of peripheral blood mononuclear cells from septic patients demonstrated that the PDHB had a major distribution in monocytes, T cells, B cells, and NK cells, and receiver operating characteristic curves confirmed the six-gene signature, including PDHB, had excellent diagnostic discrimination values.